TerrAscend (TSNDF) Interest Expenses (2020 - 2026)
TerrAscend's (TSNDF) quarterly Interest Expenses came in at $121.2 million in Q1 2026, up 5.83% year-on-year from $114.5 million in Q1 2025, and up 867.0% on a QoQ basis from -$15.8 million in Q4 2025.
TerrAscend (TSNDF) Interest Expenses (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Interest Expenses data on file, last reported at $121.2 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 5.83% year-over-year to $121.2 million in Q1 2026; TTM through Mar 2026 was $121.2 million, a 5.83% increase from a year earlier, with the FY2025 full-year figure at $112.1 million, up 307.8% from the prior year.
- Interest Expenses for Q1 2026 stood at $121.2 million, up from -$15.8 million in the prior quarter.
- Over the last five years, Interest Expenses for TSNDF reached as high as $133.1 million in Q2 2024 and fell as low as -$15.8 million in Q4 2025.
- Historically, Interest Expenses has averaged $40.0 million across 5 years, with a median of $8.3 million in 2023.
- On a YoY basis, Interest Expenses climbed as much as 1523.52% in 2025 and fell as far as 265.24% in 2025.
- Year by year, Interest Expenses stood at $6.5 million in 2022, then slipped by 2.93% to $6.4 million in 2023, then soared by 50.52% to $9.6 million in 2024, then sank by 265.24% to -$15.8 million in 2025, then surged by 867.0% to $121.2 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $121.2 million in Q1 2026, -$15.8 million in Q4 2025, and $119.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 121.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.22 Mn |
| Mar 31, 2026 | 121.22 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Sep 30, 2025 | 119.22 Mn |
| Sep 30, 2025 | 119.22 Mn |
| Jun 30, 2025 | 119.22 Mn |
| Jun 30, 2025 | 119.22 Mn |
| Mar 31, 2025 | 114.54 Mn |
| Mar 31, 2025 | 114.54 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Dec 31, 2024 | 9.56 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Jun 30, 2024 | 133.09 Mn |
| Jun 30, 2024 | 133.09 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Dec 31, 2023 | 6.35 Mn |
| Dec 31, 2023 | 6.35 Mn |